Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04732494
What this trial is testing

Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
BeiGene 125
Large-scale testing (Phase 3)Active Not RecruitingNCT01566240
What this trial is testing

Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
University College, London 500
Large-scale testing (Phase 3)Study completedNCT02578641
What this trial is testing

A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients

Who this might be right for
Nasopharyngeal Carcinoma
Tessa Therapeutics 330
Large-scale testing (Phase 3)Active Not RecruitingNCT04974398
What this trial is testing

Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Akeso 296
Early research (Phase 1)Ended earlyNCT01704209
What this trial is testing

Collagen Injections for the Treatment of Acne Scars and Wrinkles

Who this might be right for
Acne ScarsWrinkles
Northwestern University 4
Early research (Phase 1)Study completedNCT02658214
What this trial is testing

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaCarcinoma, Squamous Cell of Head and NeckStomach Neoplasms+7 more
AstraZeneca 32
Large-scale testing (Phase 3)Study completedNCT04187352
What this trial is testing

CS1001 in Subjects With Esophageal Squamous Cell Carcinoma

Who this might be right for
Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
CStone Pharmaceuticals 540
Testing effectiveness (Phase 2)WithdrawnNCT03787251
What this trial is testing

Second-line Treatment of Postoperative Recurrence and Metastasis of Esophageal Cancer Treated With Apatinib

Who this might be right for
Esophageal Neoplasms
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Large-scale testing (Phase 3)Not Yet RecruitingNCT07621601
What this trial is testing

HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Hansoh BioMedical R&D Company 494
Testing effectiveness (Phase 2)Study completedNCT03342937
What this trial is testing

KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer

Who this might be right for
Gastric CancerEsophagus Cancer
Duke University 36
Testing effectiveness (Phase 2)Study completedNCT04220307
What this trial is testing

A PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Akeso 34
Testing effectiveness (Phase 2)UnknownNCT04917770
What this trial is testing

The Efficacy and Safety of Sintilimab in Combination With Multimodal Radiotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
West China Hospital 28
Large-scale testing (Phase 3)Study completedNCT03783442
What this trial is testing

Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
BeiGene 649
Testing effectiveness (Phase 2)UnknownNCT03130270
What this trial is testing

Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Guilin Medical University, China 29
Testing effectiveness (Phase 2)Ended earlyNCT03386357
What this trial is testing

Radiotherapy With Pembrolizumab in Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University of Erlangen-Nürnberg Medical School 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT03764553
What this trial is testing

Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer

Who this might be right for
Esophageal Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 320
Not applicableWithdrawnNCT03161613
What this trial is testing

Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico

Who this might be right for
Multiple Indications Cancer
Bristol-Myers Squibb
Large-scale testing (Phase 3)Not Yet RecruitingNCT04890522
What this trial is testing

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

Who this might be right for
Nasopharyngeal CarcinomaMetastasisChemotherapy+2 more
Sun Yat-sen University 622
Testing effectiveness (Phase 2)WithdrawnNCT05998941
What this trial is testing

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Testing effectiveness (Phase 2)UnknownNCT05170256
What this trial is testing

Trastuzumab and Standard Treatment With Chemo- and Immunotherapy as First Line Treatment for HER2 Positive Esophageal Squamous Cell Carcinoma Patients

Who this might be right for
Esophageal Squamous Cell CarcinomaHER-2 Protein OverexpressionHER-2 Gene Amplification
Morten Mau-Sørensen 24
Next Page